Workplace Testing

Drug-Free Workplace

No workplace is immune to employee substance abuse. Aegis is committed to ensure your organization, whether a small business or Fortune 500 corporation, is truly drug-free.

26 + Years Experience + Zero-Tolerance program + Oral Fluid option

26 + Years Experience

26 + Years Experience

Aegis has helped employers be drug-free since 1991.

Learn More

No workplace is immune to employee substance abuse and yet many companies struggle to identify solutions to this growing problem. Let Aegis help by offering more than 26 years of experience providing best-in-class drug testing programs that support the unique needs of your workplace. 

Zero-Tolerance Drug Testing Services

Zero-Tolerance Drug Testing Services

Other labs & onsite devices miss 60-70% of detectable drug use!

Learn More

Our Zero-Tolerance Drug Testing® Services detect more drugs

Did you realize routine testing by other laboratories and point-of-care onsite devices miss 60-70% of detectable drug use?

With Zero-Tolerance Drug Testing services, you can ensure your workplace is truly Drug-Free.

Zero-Tolerance Drug Testing services detect:

  • More Drugs
  • Drugs at lower thresholds
  • Drugs for a longer period of time
Oral Fluid Option

Oral Fluid Option

Oral fluid simplifies the collection process and ensures that a sample can be collected every time.

Learn More

Aegis provides an oral fluid collection option

If a urine sample cannot be collected, Aegis offers Oral Fluid and Blood testing. These specimen types ensure that a sample can be collected by every donor. It is quick, easy and available through Aegis.

Designer Drug Testing Available

  • Synthetic Cannabinoids (Spice, K2, Fake Pot)

    Synthetic Cannabinoids (Spice, K2, Fake Pot)

    Synthetic Cannabinoids are designer chemicals that mimic the effects of THC, the active component of marijuana. However, these compounds are structurally unrelated to THC and cannot be detected by standard marijuana drug tests. For this reason, use of these products has become very popular among drug users seeking a "high" without the danger of being detected by drug testing programs.

    Method of use:

    Spice products have been marketed as household aromatics, fragrances or incenses and are typically labeled “Not for Human Consumption”; but at least some of the products contain compounds that have the same pharmacological effects as cannabinoids (marijuana and Hashish). Therefore, these products can be smoked or otherwise ingested, and users experience effects very similar to those of marijuana.

    Regulatory status:

    On November 24, 2010, the Drug Enforcement Agency temporarily placed five synthetic cannabinoids into schedule I of the Controlled Substance Act: JWH-018, JWH-073, JWH-200, CP-47, 497, and cannabicyclohexanol. The ban went into legal effect on March 1, 2011.


    The use of synthetic cannbinoids is rapidly increasing. Poison control centers in the United States have reported more calls related to synthetic cannabinoids during the first six months of 2011 than all of 2010.

    Laboratory testing:

    Aegis now performs tests for 21 metabolites of 11 synthetic cannabinoids using LC/MS/MS with a 1 ng/ml threshold.

    What ARE the different names being used?:

    Most synthetic cannabinoids are marketed as drug-laced herbal incense products called “Spice,” “K2,” “Black Mamba,” “K3” “potpourri,” among many others.

    Learn More
  • Bath Salts

    Bath Salts

    Bath salts, scientifically known as synthetic cathinones, are the newest designer drugs to emerge in the drug abuse scene. They possess stimulant effects similar to ecstasy (MDMA) and are often called "fake cocaine." "Bath salts" are named such to escape attention as an illicit substance. They are not hygiene products but rather are intended for substance abuse - although packaging typically includes a token "Not for Human Consumption" label.

    Method of use:

    The routes of administration are reported to be oral, injection, smoking, snorting and less often by atomization (similar to vaporizing). Worse outcomes are usually associated with injection or inhalation routes.

    Regulatory status:

    Mephedrone is an analogue methcathinine, which is Classified as a Schedule I substance under the Controlled Substances ACT (CSA).


    Law enforcement officials report increasing use, especially among youth. It has been suggested that individuals who abuse synthetic cathinone products may exhibit more extreme behaviors related to their addictions.

    Laboratory testing:

    Aegis has developed a test for synthetic cathinones using LC/MS/MS screening and confirmation methods, with a threshold of 25 ng/ml.

    Learn More

Aegis Offers

  • Pre-employment
  • Random
  • Post-accident
  • Reasonable suspicion
  • Zero-Tolerance Drug Testing services


For more information or to begin testing, please contact us at 800.533.7052

Aegis HealthPro™ Testing Services

We meet your specialized needs as a healthcare organization. With your increased liability and safety concerns, you need the most comprehensive drug testing services available.

  • HealthPro™ Profile

    HealthPro™ Profile

    Using our Zero-Tolerance Drug Testing philosophy, Aegis created the HealthPro™ profile to include drugs often found in a healthcare setting, such as hydrocodone, oxycodone, hydromorphone and many others that generally go undetected by other laboratory testing and onsite testing devices.

  • Impaired Healthcare Professional Testing

    Impaired Healthcare Professional Testing

    Because healthcare employees have greater access to a larger variety of drugs, your drug testing program must be able to detect an extensive list of drugs when confronted with a potential impaired professional situation.

  • Tampered Pharmaceutical Testing

    Tampered Pharmaceutical Testing

    We can provide analysis of pharmaceutical or unidentified products suspected of being tampered.

  • Solid Dose Drug Identification

    Solid Dose Drug Identification

    We provide analysis of pills, tablets, syringes and other suspected drug products.

For more information or to begin testing, please contact us at 800.533.7052